JOY JESSUP: Open Payments
NPI 1366072365 · KERNERSVILLE, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$811 in 47 payments from 16 companies in 2025. Trend: 2023 $866 · 2024 $1,273 · 2025 $811
Food & beverage: $811
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 16 | $212 |
| AstraZeneca Pharmaceuticals LP | 5 | $89 |
| Novo Nordisk Inc | 4 | $68 |
| Lilly USA, LLC | 3 | $63 |
| PFIZER INC. | 3 | $60 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 3 | $51 |
| Astellas Pharma US Inc | 2 | $45 |
| Ardelyx, Inc. | 2 | $38 |
| SANOFI-AVENTIS U.S. LLC | 1 | $34 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 2 | $31 |
Products named: VRAYLAR, CAPLYTA, REXULTI, Veozah, FARXIGA, JARDIANCE, ELIQUIS, IBSRELA.
Industry payments across NC — which companies pay providers there.
